Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10

Mise à jour : Il y a 4 ans
Référence : NCT00168038

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy, tolerability and safety of IgPro10 in the treatment of patients with chronic immune thrombocytopenic purpura (ITP). The main efficacy parameter is the proportion of patients responding to treatment by an increase of platelet count to ≥ 50 x 10^9/L.


Critère d'inclusion

  • Immune Thrombocytopenic Purpura


Liens